Literature DB >> 21707436

The Roche Elecsys and Siemens-Centaur thyroglobulin autoantibody assays show comparable clinical performance to the recently unavailable Beckman-Coulter access thyroglobulin autoantibody assay in identifying samples with potentially false-low thyroglobulin measurements due to thyroglobulin autoantibody interference.

Alicia Algeciras-Schimnich, Michael A Lasho, Karl M Ness, Lynn A Cheryk, Stefan K G Grebe.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21707436      PMCID： PMC3123526          DOI： 10.1089/thy.2011.0158

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  3 in total

1.  Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays.

Authors:  Sonia L La'ulu; Patricia R Slev; William L Roberts
Journal:  Clin Chim Acta       Date:  2006-07-25       Impact factor: 3.786

2.  Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer.

Authors:  C Spencer; I Petrovic; S Fatemi
Journal:  J Clin Endocrinol Metab       Date:  2011-02-16       Impact factor: 5.958

3.  Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.

Authors:  C A Spencer; L M Bergoglio; M Kazarosyan; S Fatemi; J S LoPresti
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958
  3 in total
  5 in total

1.  Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low- and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine.

Authors:  Lawrence Kashat; Steven Orlov; David Orlov; Jasmeet Assi; Farnaz Salari; Paul G Walfish
Journal:  Endocrine       Date:  2016-05-17       Impact factor: 3.633

2.  Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.

Authors:  Carole Spencer; Ivana Petrovic; Shireen Fatemi; Jonathan LoPresti
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

3.  Variation in Results Release and Patient Portal Access to Diagnostic Test Results at an Academic Medical Center.

Authors:  Matthew D Krasowski; Caleb V Grieme; Brian Cassady; Nicholas R Dreyer; Karolyn A Wanat; Maia Hightower; Kenneth G Nepple
Journal:  J Pathol Inform       Date:  2017-11-23

4.  Thyroid heterogeneity, as indicated by the CV of ultrasonographic intensities, correlates with anti-thyroid peroxidase antibodies in euthyroid Hashimoto's thyroiditis.

Authors:  Yosuke Wakita; Toshiki Nagasaki; Yuki Nagata; Yasuo Imanishi; Shinsuke Yamada; Koichiro Yoda; Masanori Emoto; Eiji Ishimura; Masaaki Inaba
Journal:  Thyroid Res       Date:  2013-03-23

Review 5.  Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.

Authors:  Luca Giovanella; Penelope M Clark; Luca Chiovato; Leonidas Duntas; Rossella Elisei; Ulla Feldt-Rasmussen; Laurence Leenhardt; Markus Luster; Camilla Schalin-Jäntti; Matthias Schott; Ettore Seregni; Herald Rimmele; Jan Smit; Frederik A Verburg
Journal:  Eur J Endocrinol       Date:  2014-04-17       Impact factor: 6.664
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.